EX-99.2 3 exhibit99-2.htm EXHIBIT 99.2 Kelso Technologies Inc.: Exhibit 99.2 - Filed by newsfilecorp.com

KELSO TECHNOLOGIES INC.

Consolidated Interim Financial Statements
For the six months ended June 30, 2016
(Unaudited – Prepared by Management)
(Expressed in US Dollars)

Index Page
   
Notice of no Auditor Review of Interim Financial Report 2
   
Consolidated Interim Financial Statements  
   
   Consolidated Interim Statements of Financial Position 3
   
   Consolidated Interim Statements of Changes in Equity 4
   
   Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 5
   
   Consolidated Interim Statements of Cash Flows 6
   
Notes to Consolidated Interim Financial Statements 7 – 25


NOTICE OF NO AUDITOR REVIEW OF INTERIM FINANCIAL REPORT

The accompanying unaudited interim financial report of the Company has been prepared by and is the responsibility of the Company’s management. The Company’s independent auditor has not performed a review of this financial report.

2


Kelso Technologies Inc.
Consolidated Interim Statements of Financial Position
June 30, 2016
(Unaudited – Prepared by Management)
(Expressed in US Dollars)

    June 30,     December 31,  
    2016     2015  
             
Assets            
Current            
 Cash and cash equivalents $  2,963,611   $  3,175,292  
 Accounts receivable   1,158,848     1,706,488  
 Prepaid expenses   634,421     1,103,498  
 Income tax receivable   683,163     683,163  
 Inventory (Note 6)   6,138,559     5,981,919  
    11,578,602     12,650,360  
             
Intangible assets (Note 8)   17,879     19,391  
Property, plant and equipment (Note 7)   3,276,192     3,396,893  
Deposit   4,113     4,113  
Deferred income tax asset   86,932     86,932  
             
Total Assets $  14,963,718   $  16,157,689  
             
Liabilities            
Current            
 Accounts payable and accrued liabilities (Note 10) $  509,767   $  546,698  
 Income tax payable   2,034,390     2,004,272  
             
Total Liabilities $  2,544,157   $  2,550,970  
             
Shareholders’ Equity            
Capital Stock (Note 9)   22,515,140     22,515,140  
Reserves (Note 9 (b))   2,941,233     2,898,148  
Deficit   (13,036,812 )   (11,806,569 )
             
Total Shareholders’ Equity   12,419,561     13,606,719  
             
Total Liabilities and Shareholders’ Equity $  14,963,718   $  16,157,689  

Approved on behalf of the Board:

Peter Hughes” (signed)  
Peter Hughes, Director  
   
Phil Dyer” (signed”)  
Phil Dyer, Director  

See notes to consolidated interim financial statements

3


Kelso Technologies Inc.
Consolidated Interim Statements of Changes in Equity
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)

    Capital Stock           Share-based              
    Number           Share     expenses              
    of shares     Amount     subscriptions     reserve     Deficit     Total  
                                     
Balance, December 31, 2014   45,246,752   $  22,141,417   $  -   $  2,375,598   $  (7,918,089 ) $  16,598,926  
Exercise of options   675,000     199,426     -     -     -     199,426  
Share-based expense   -     -     -     540,000     -     540,000  
Dividends paid   -     -     -     -     (1,377,653 )   (1,377,653 )
Net income for the period   -     -     -     -     433,952     433,952  
Balance, June 30, 2015   45,921,752   $  22,340,843   $  -   $  2,915,598   $  (8,861,790 ) $  16,394,651  
                                     
Balance, December 31, 2015   46,071,752   $  22,515,140   $  -   $  2,898,148   $  (11,806,569 ) $  13,606,719  
Share-based expense   -     -     -     43,085     -     43,085  
Net loss for the period   -     -     -     -     (1,230,243 )   (1,220,073 )
Balance, June 30, 2016   46,071,752   $  22,515,140   $  -   $  2,941,233   $  13,036,812   $  12,419,561  

See notes to consolidated interim financial statements

4


Kelso Technologies Inc.
Consolidated Interim Statements of Operations and Comprehensive Income (Loss)
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)

    Three     Three              
    months     months     Six months     Six months  
    ended     ended     ended     ended  
    June 30,     June 30,     June 30,     June 30,  
    2016     2015     2016     2015  
                         
Revenues $  2,360,975   $  4,596,741   $  4,294,407   $ 11,468,425  
Cost of Goods Sold   1,422,096     3,222,439     2,981,372     7,127,021  
                         
Gross Profit   938,879     1,374,302     1,313,035     4,341,404  
                         
Expenses                        
 Share-based expense (Note 9 (b))   -     -     43,085     540,000  
 Management fees (Note 10)   194,704     243,392     350,764     549,834  
 Consulting and filing fees   58,729     188,950     118,060     386,070  
 Investor relations   21,000     21,000     42,000     43,330  
 Accounting and legal   80,930     75,036     162,675     164,212  
 Office and administration   581,683     439,245     1,076,656     741,673  
 Research   262,036     202,933     398,305     380,891  
 Travel   95,678     109,080     166,116     200,160  
 Marketing   181,042     194,915     343,672     400,918  
Unrealized foreign exchange loss (gain) (15,827 ) (283,621 ) (173,409 ) 132,411
                         
    1,459,975     1,190,930     2,527,924     3,496,169  
                         
Income (Loss) before the following   (521,096 )   183,372     (1,214,889 )   845,235  
Interest income   7,375     25,710     14,764     36,996  
Income tax   (30,118 )   (103,999 )   (30,118 )   (448,279 )
                         
Net Income (Loss) and Comprehensive Income (Loss) for the Period $ (543,839 ) $ 105,083 $ (1,230,243 ) $ 433,952
                         
Basic and Diluted Earnings (Loss) Per Share $ (0.01 ) $ 0.00 $ (0.03 ) $ 0.01
                         
Weighted Average Number of Common Shares Outstanding
Basic   46,071,752     45,388,943     46,071,752     45,388,943  
Diluted   46,520,323     46,757,514     46,520,323     46,757,514  

See notes to consolidated interim financial statements

5


Kelso Technologies Inc.
Consolidated Interim Statements of Cash Flows
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)

    June 30,     June 30,  
    2016     2015  
             
Operating Activities            
 Net income (loss) $  (1,230,243 ) $  433,952  
 Items not involving cash            
     Amortization of equipment and patent   128,550     135,946  
     Share-based expense   43,085     540,000  
     Unrealized foreign exchange   (173,409 )   132,411  
             
    (1,232,017 )   1,242,309  
             
Changes in non-cash working capital            
 Accounts receivable   547,640     1,008,699  
 Prepaid expenses and deposit   469,077     (278,832 )
 Inventory   (156,640 )   (3,293,382 )
 Accounts payable and accrued liabilities   (36,931 )   (1,474,471 )
 Income tax payable   30,118     (569,874 )
             
    853,264     (4,607,860 )
             
Cash Used in Operating Activities   (378,753 )   (3,365,551 )
             
Investing Activities            
 Property and equipment   (6,337 )   (211,421 )
 Intangible assets   -     (502,913 )
             
Cash Used in Investing Activities   (6,337 )   (714,334 )
             
Financing Activities            
 Issue of common shares   -     199,426  
 Dividend paid   -     (1,377,653 )
             
Cash Used in Financing Activities   -     (1,178,227 )
Foreign exchange effect on cash   173,409     (132,411 )
             
Inflow (Outflow) of Cash   (211,681 )   (5,390,523 )
Cash, Beginning of Period   3,175,292     9,895,463  
             
Cash, End of Period $  2,963,611   $  4,504,940  

Supplemental Cash Flow Information (Note 12)

See notes to consolidated interim financial statements

6



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

1.

NATURE OF OPERATIONS

Kelso Technologies Inc. (the “Company”) designs, engineers, markets, produces and distributes various proprietary pressure relief valves and manway securement systems designed to reduce the risk of environmental harm due to non-accidental events in the transportation of hazardous commodities via railroad tank cars. The Company trades on the Toronto Stock Exchange (“TSX”) under the symbol “KLS”, and the NYSE (“NYSE”) under the trading symbol “KIQ”. The Company listed on the Toronto Stock Exchange on May 22, 2014 and on the NYSE Markets Exchange on October 14, 2014. The Company’s head office is located at 13966 - 18B Avenue South Surrey, BC V4A 8J1.

2.

BASIS OF PREPARATION


  (a)

Statement of compliance

These unaudited interim consolidated financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (“IFRS”), as issued by International Accounting Standards Board (“IASB”), applicable to the preparation of interim financial statements, including International Accounting Standards (“IAS”) 34 Interim Financial Reporting. The condensed unaudited interim financial statements do not include all of the disclosures required for a complete set of annual financial statements and should be read in conjunction with the audited annual consolidated financial statements for the year ended December 31, 2015, which have been prepared in accordance with IFRS as issued by the IASB.

  (b)

Basis of presentation and consolidation

The consolidated financial statements include the accounts of the Company and its integrated wholly-owned subsidiaries, Kelso Technologies (USA) Inc. and Kelso Innovative Solutions Inc.; both are Nevada, USA, corporations. Intercompany transactions and balances have been eliminated.

  (c)

Functional and presentation currency

The functional and presentation currency of the Company and its subsidiaries is the US dollar (“USD”).

  (d)

Significant management judgment and estimation uncertainty

The preparation of consolidated financial statements in conformity with IFRS requires the Company’s management to undertake a number of judgments, estimates and assumptions that affect amounts reported in the consolidated financial statements and notes thereto. Actual amounts may ultimately differ from these estimates and assumptions. The Company reviews its estimates and underlying assumptions on an ongoing basis. Revisions are recognized in the period in which the estimates are revised and may impact future periods.

7



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

2.

BASIS OF PREPARATION (Continued)


  (d)

Significant management judgment and estimation uncertainty (Continued)

Significant management judgments

The following are significant management judgments in applying the accounting policies of the Company that have the most significant effect on recognition and measurement of assets, liabilities, income and expenses:

  (i)

Recognition of deferred tax assets

The extent to which deferred tax assets can be recognized is based on an assessment of the probability of the Company’s future taxable income against which the deferred tax assets can be utilized. In addition, significant judgment is required in assessing the impact of any legal or economic limits or uncertainties in various tax jurisdictions.

  (ii)

Functional currency

The functional currency for the Company’s subsidiaries is the currency of the primary economic environment in which the entity operates. The Company has determined the functional currency and that of its subsidiaries is the USD. Determination of functional currency may involve certain judgments to determine the primary economic environment and the Company reconsiders the functional currency of its entities if there is a change in events and conditions that determined the primary economic environment.

Estimation uncertainty

Information about estimates and assumptions that have the most significant effect on the recognition and measurement of assets, liabilities, income and expenses is provided below. Actual results may be substantially different.

  (i)

Impairment of long-lived assets

Long-lived assets consist of intangible assets, property, plant and equipment, and deferred product costs.

At the end of each reporting period, the Company reviews the carrying amounts of its non-current assets to determine whether there is any indication that the carrying amount is not recoverable. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). When an individual asset does not generate independent cash flows, the Company estimates the recoverable amount of the cash-generating unit to which the asset belongs. Assets are grouped together into the smallest group of assets that generates cash inflows from continuing use that are largely independent of the cash inflows of other assets or groups of assets. When a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.

8



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

2.

BASIS OF PREPARATION (Continued)


  (d)

Significant management judgment and estimation uncertainty (Continued)

Estimation uncertainty (Continued)

  (i)

Impairment of long-lived assets (Continued)

Recoverable amount is the higher of fair value less costs of disposal and value in use. Fair value is determined as the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognized immediately in profit or loss.

When an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognized immediately in profit or loss.

  (ii)

Useful lives of depreciable assets

The Company reviews its estimate of the useful lives of depreciable assets at each reporting date, based on the expected utilization of the assets. Uncertainties in these estimates relate to technical obsolescence that may change the utilization of certain intangible assets and equipment.

  (iii)

Inventories

The Company estimates the net realizable values of inventories, taking into account the most reliable evidence available at each reporting date. The future realization of these inventories may be affected by future technology or other market-driven changes that may reduce future selling prices. A change to these assumptions could impact the Company’s inventory valuation and impact gross margins.

  (iv)

Share-based expense

The Company grants share-based awards to certain officers, employees, directors and other eligible persons. For equity settled awards, the fair value is charged to the consolidated statement of operations and comprehensive income and credited to the reserves, over the vesting period using the graded vesting method, after adjusting for the estimated number of awards that are expected to vest.

9



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

2.

BASIS OF PREPARATION (Continued)


  (d)

Significant management judgment and estimation uncertainty (Continued)

Estimation uncertainty (Continued)

  (iv)

Share-based expense (Continued)

The fair value of the equity-settled awards is determined at the date of the grant using the Black-Scholes option pricing model. Option pricing models require the input of highly subjective assumptions, including the expected price, expected volatility and expected life of the options. Changes in these assumptions can materially affect the fair value estimate, and therefore, the existing models do not necessarily provide a reliable measure of the fair value of the Company’s stock options.

  (v)

Allowance account for credit losses

The Company provides for bad debt by analyzing the historical default experience and current information available about customer’s credit worthiness on an account by account basis. Uncertainty relates to the actual collectability of customer balances that can vary from the Company’s estimation.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected.

  (e)

Approval of the consolidated financial statements

The unaudited interim consolidated financial statements of Kelso Technologies Inc. for the period ended June 30, 2016 were approved and authorized for issue by the Board of Directors on August 9, 2016.

  (f)

New accounting standards issued but not yet effective

IFRS 9 Financial Instruments

IFRS 9 was issued by the IASB in October 2010. It incorporates revised requirements for the classification and measurement of financial liabilities and carrying over the existing derecognition requirements from IAS 39 Financial Instruments: Recognition and Measurement. The revised financial liability provisions maintain the existing amortized cost measurement basis for most liabilities. New requirements apply where an entity chooses to measure a liability at fair value through profit or loss; in these cases, the portion of the change in fair value related to changes in the entity's own credit risk is presented in other comprehensive income rather than within profit or loss. IFRS 9 is effective for the Company’s annual period beginning on January 1, 2018. The impact of IFRS 9 on the Company’s consolidated financial statements has not yet been determined.

IFRS 15 Revenue from Contracts with Customers

IFRS 15 provides a single, principles based five-step model to be applied to all contracts with customers.

10



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

2.

BASIS OF PREPARATION (Continued)


  (f)

New accounting standards issued but not yet effective (Continued)

IFRS 15 Revenue from Contracts with Customers (Continued)

The five steps in the model are as follows:

  Identify the contract with the customer
     
  Identify the performance obligations in the contract
     
  Determine the transaction price
     
  Allocate the transaction price to the performance obligations in the contracts
     
  Recognize revenue when (or as) the entity satisfies a performance obligation.

Guidance is provided on topics such as the point in which revenue is recognized, accounting for variable consideration, costs of fulfilling and obtaining a contract and various related matters. New disclosures about revenue are also introduced. IFRS is applicable to the Company’s annual period beginning on January 1, 2018.

Clarification of Acceptable Methods of Depreciation and Amortization (Amendments to IAS 16 and IAS 38)

Amends IAS 16 Property, Plant and Equipment and IAS 38 Intangible Assets to:

clarify that a depreciation method that is based on revenue that is generated by an activity that includes the use of an asset is not appropriate for property, plant and equipment

 

introduce a rebuttable presumption that an amortization method that is based on the revenue generated by an activity that includes the use of an intangible asset is inappropriate, which can only be overcome in limited circumstances where the intangible asset is expressed as a measure of revenue, or when it can be demonstrated that revenue and the consumption of the economic benefits of the intangible asset are highly correlated

 

add guidance that expected future reductions in the selling price of an item that was produced using an asset could indicate the expectation of technological or commercial obsolescence of the asset, which, in turn, might reflect a reduction of the future economic benefits embodied in the asset.

Applicable to the Company’s annual period beginning January 1, 2016.

IFRS 16 Leases

IFRS 16 specifies how an IFRS reporter will recognize, measure, present and disclose leases. The standard provides a single lessee accounting model, requiring lessees to recognize assets and liabilities for Applicable to all leases unless the lease term is 12 months or less or the underlying asset has a low value. Lessors continue to classify leases as operating or finance, with IFRS 16’s approach to lessor accounting substantially unchanged from its predecessor, IAS 17 Leases.

11



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

2.

BASIS OF PREPARATION (Continued)


  (f)

New accounting standards issued but not yet effective (Continued)

IFRS 16 Leases (Continued)

Applicable to the Company’s annual period beginning January 1, 2019.

The impact of the above new accounting standards on the Company’s consolidated financial statements has not yet been determined.

3.

SIGNIFICANT ACCOUNTING POLICIES

The following is a summary of significant accounting policies.

  (a)

Cash equivalents

Cash equivalents include short-term liquid investments with maturities of 90 days or less, are readily convertible into known amounts of cash and which are subject to insignificant changes in value.

  (b)

Inventory

Inventory components include raw materials and supplies used to assemble valves and manway covers, as well as finished valves and manway covers. All inventories are recorded at the lower of cost on a weighted average basis and net realizeable value. The stated value of all inventories includes purchase and assembly costs of all raw materials and supplies, and attributable overhead and amortization. A regular review is undertaken to determine the extent of any provision for obsolescence.

  (c)

Intangible assets

The Company’s intangible assets include manway patents and eduction tube line (“ETS”) rights.

The patents are capitalized and amortized on a straight-line basis over their thirteen-year protective term. The rights are capitalized and amortized on a straight-line basis over their two-year useful life.

  (d)

Amortization

Property, plant and equipment are stated at cost less accumulated amortization. Leasehold improvements are amortized on a straight-line basis over the lease term. Amortization is calculated over the estimated useful life of the property, plant and equipment on a declining-balance basis at the following annual rates:

Building – 4%
Production equipment – 20%
Vehicles – 30%
Leasehold improvements – 20% straight-line

12



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (Continued)


  (e)

Revenue recognition

Revenues are recognized when the risks and rewards of ownership have passed to the customer based on the terms of the sale, collection of the relevant receivable is probable, evidence of an arrangement exists and the sales price is fixed or determinable. Risks and rewards of ownership pass to the customer upon shipment of the pressure relief valves and/or manway securement systems, unless otherwise agreed upon. Provisions for sales discounts and returns from customers are made at the time of sale.

  (f)

Impairment of non-current assets

The Company’s tangible and intangible assets are reviewed for an indication of impairment at each statement of financial position date. If indication of impairment exists, the asset’s recoverable amount is estimated. An impairment loss is recognized when the carrying amount of an asset, or its cash-generating unit, exceeds its recoverable amount. A cash-generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of cash inflow from other assets or groups of assets.

The recoverable amount is the greater of the asset’s fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the assets. For an asset that does not generate largely independent cash inflows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

  (g)

Income taxes

       
 

(i)

Current and deferred income taxes

Income tax expense, consisting of current and deferred tax expense, is recognized in the consolidated statements of operations. Current tax expense is the expected tax payable on the taxable income for the period, using tax rates enacted or substantively enacted at period-end, adjusted for amendments to tax payable with regard to previous years.

Deferred tax assets and liabilities and the related deferred income tax expense or recovery are recognized for deferred tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted or substantively enacted tax rates expected to apply when the asset is realized or the liability settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income (loss) in the period that substantive enactment occurs.

13



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (Continued)


  (g)

Income taxes (Continued)

       
 

(i)

Current and deferred income taxes (Continued)

A deferred tax asset is recognized to the extent that it is probable that future taxable profits will be available against which the asset can be utilized. To the extent that the Company does not consider it probable that a deferred tax asset will be recovered, the deferred tax asset is reduced. Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off current tax assets against current tax liabilities and when they relate to income taxes levied by the same taxation authority and the Company intends to settle its current tax assets and liabilities on a net basis.

  (ii)

Texas margin tax

Effective January 1, 2007, the state of Texas enacted an annual franchise tax known as the Texas margin tax, which is equal to 1% of the lesser of: (a) 70% of a taxable entity’s revenue; and (b) 100% of total revenue less, at the election of the taxpayer: (i) cost of goods sold; or (ii) compensation.

  (h)

Foreign currency translation

The accounts of foreign balances and transactions are translated into USD as follows:

  (i)

Monetary assets and liabilities, at the rate of exchange in effect at the consolidated statement of financial position date;

     
  (ii)

Non-monetary assets and liabilities, at the exchange rates prevailing at the time of the acquisition of the assets or assumption of the liabilities; and

     
  (iii)

Revenue and expense items (excluding amortization, which is translated at the same rate as the related asset), at the rate of exchange prevailing at the transaction date.

Gains and losses arising from translation of foreign currency are included in the determination of net income (loss).

  (i)

Earnings per share

The Company presents basic earnings per share data for its common shares, calculated by dividing the earnings attributable to common shareholders of the Company by the weighted average number of shares outstanding during the period. The Company uses the treasury stock method for calculating diluted earnings per share. Under this method the dilutive effect on earnings per share is calculated on the use of the proceeds that could be obtained upon exercise of options, warrants and similar instruments. It assumes that the proceeds of such exercise would be used to purchase common shares at the average market price during the period. However, the calculation of diluted loss per share excludes the effects of various conversions and exercise of options and warrants that would be anti-dilutive.

14



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (Continued)


  (j)

Share-based expense

The Company grants share options to acquire common shares of the Company to directors, officers, employees and consultants. The fair value of share-based expense to employees is measured at grant date, using the Black-Scholes option pricing model, and is recognized over the vesting period for employees using the graded vesting method. Fair value of share-based expenses for non-employees is recognized and measured at the date the goods or services are received based on the fair value of the goods or services received. If it is determined that the fair value of goods and services received cannot be reliably measured, the share-based expense is measured at the fair value of the equity instruments issued using the Black-Scholes option pricing model.

For both employees and non-employees, the fair value of share-based expense is recognized on the statements of operations and comprehensive income (loss), with a corresponding increase in reserves. The amount recognized as expense is adjusted to reflect the number of share options expected to vest. Consideration received on the exercise of stock options is recorded in capital stock and the related share-based expense in reserves is transferred to capital stock.

  (k)

Capital stock

Proceeds from the exercise of stock options and warrants are recorded as capital stock in the amount for which the option or warrant enabled the holder to purchase a share in the Company. Any previously recorded share-based expense included in the share-based expenses reserve is transferred to capital stock on exercise of options. Capital stock issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and warrants based on the residual value method. Under this method, the proceeds are allocated first to capital stock based on the fair value of the common shares at the time the units are priced and any residual value is allocated to the warrants reserve. Consideration received for the exercise of warrants is recorded in capital stock, and any related amount recorded in warrants reserve is transferred to capital stock.

  (l)

Financial instruments


  (i)

Financial assets

The Company classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Company’s accounting policy for each category is as follows:

Fair value through profit or loss

This category comprises derivatives, or assets acquired or incurred principally for the purpose of selling or repurchasing it in the near term. They are carried at fair value with changes in fair value recognized through profit or loss. Cash and cash equivalents are included in this category of financial assets.

15



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (Continued)


  (l)

Financial instruments (Continued)


  (i)

Financial assets (Continued)

Loans and receivables

These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They are carried at cost less any provision for impairment. Individually significant receivables are considered for impairment when they are past due or when other objective evidence is received that a specific counterparty will default. Accounts receivable are included in this category of financial assets.

  (ii)

Financial liabilities

The Company classifies its financial liabilities in the following category:

Other financial liabilities

Other financial liabilities are non-derivatives and are recognized initially at fair value, net of transaction costs incurred, and are subsequently stated at amortized cost using the effective interest rate method. Any difference between the amounts originally received, net of transaction costs, and the redemption value is recognized in profit or loss over the period to maturity using the effective interest method. Other financial liabilities are classified as current or non-current based on their maturity date. Accounts payable is included in this category of financial liability.

Other financial liabilities are classified as current or non-current based on their maturity date.

4.

CAPITAL MANAGEMENT

The Company considers its capital to be comprised of shareholders’ equity.

The Company’s objectives in managing its capital are to maintain its ability to continue as a going concern and to further develop its business. To effectively manage the Company’s capital requirements, the Company has a planning and budgeting process in place to meet its strategic goals.

In order to facilitate the management of its capital requirements, the Company prepares expenditure budgets that are updated as necessary depending on various factors, including successful capital deployment and general industry conditions. Management reviews the capital structure on a regular basis to ensure the above objectives are met. There have been no changes to the Company’s approach to capital management during the period. There are no externally imposed restrictions on the Company’s capital.

16



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

5.

FINANCIAL INSTRUMENTS

Financial instruments are agreements between two parties that result in promises to pay or receive cash or equity instruments. The Company classifies its financial instruments as follows: cash is classified as a financial asset at FVTPL, accounts receivable is classified as loans and receivables, and accounts payable and accrued liabilities are classified as other financial liabilities, which are measured at amortized cost. The carrying value of these instruments approximates their fair values due to their short term to maturity.

The Company has exposure to the following risks from its use of financial instruments:

  Credit risk;
     
  Liquidity risk; and
     
  Market risk.

  (a)

Credit risk

Credit risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. Cash and cash equivalents are placed with major Canadian and US financial institutions and the Company’s concentration of credit risk for cash and cash equivalents and maximum exposure thereto is $2,963,611 (2015 - $3,175,292).

With respect to its accounts receivable, the Company assesses the credit rating of all customers and maintains provisions for potential credit losses, and any such losses to date have been within management’s expectations. The Company’s credit risk with respect to accounts receivable and maximum exposure thereto is $1,158,848 (2015 - $1,706,488). The Company’s concentration of credit risk for accounts receivable with respect to Customers (Note 14) is as follows: Customer A is $637,643 (2015 - $894,224), while Customer B is $116,720 (2015 - $236,037). The Company has no balances past due or impaired.

  (b)

Liquidity risk

Liquidity risk is the risk that the Company will be unable to meet its financial obligations as they fall due. The Company’s approach to managing liquidity risk is to ensure, as far as possible, that it will have sufficient liquid funds to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation. At June 30, 2016, the Company has $2,963,611 (2015 - $3,175,292) of cash and cash equivalents to settle current liabilities of $508,767 (2015 - $546,698) with the following due dates: trade accounts payable of $506,622 (2015 - $543,903); management bonus payable of $Nil (2015 - $Nil) and; due to related party balance of $3,145 (2015 - $2,795). All payables are due within a year.

17



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

5.

FINANCIAL INSTRUMENTS (Continued)


  (c)

Market risk

The significant market risks to which the Company is exposed are interest rate risk and currency risk.

  (i)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows will fluctuate as a result of changes in market interest rates. The Company’s cash and cash equivalents consist of cash held in bank accounts and short-term liquid investments that earn interest at variable rates. Due to the short-term nature of these financial instruments, fluctuations in market rates of interest do not have a significant impact on the estimated fair value or future cash flows.

  (ii)

Currency risk

The Company is exposed to currency risk to the extent expenditures incurred or funds received and balances maintained by the Company are denominated in Canadian dollars (“CAD”). The Company does not manage currency risk through hedging or other currency management tools.

As at June 30, 2016 and December 31, 2015, the Company’s had the following assets denominated in CAD (amounts presented in USD):

      June 30, 2016     December 31, 2015  
               
  Cash $  2,382,394   $  2,243,903  
  Accounts receivable   8,835     16,687  
  Accounts payable   (52,053 )   (53,845 )
               
    $  2,339,176   $  2,206,745  

Based on the above, assuming all other variables remain constant, a 16% weakening or strengthening of the USD against the CAD would result in approximately $374,268 (2015 - $353,000) foreign exchange loss or gain in the consolidated statements of operations and comprehensive income (loss).

  (iii)

Other price risk

Other price risk is the risk that the future cash flows of a financial instrument will fluctuate due to changes in market prices, other than those arising from interest rate risk or currency risk. The Company is not exposed to other price risk.

18



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

6.

INVENTORY


      June 30, 2016     December 31, 2015  
  Finished goods $  247,322   $  387,180  
  Raw materials and supplies   5,891,237     5,594,739  
    $  6,138,559   $  5,981,919  

Included in cost of goods sold is $1,143,570 (2015 - $3,141,965) of direct material costs recognized as expense.

7.

PROPERTY, PLANT AND EQUIPMENT


                  Leasehold     Production              
  Cost   Land     Building     improvements     equipment     Vehicles     Total  
                                       
  Balance, December 31, 2014 $  12,558   $ 2,937,966   $  43,715   $  579,493   $  28,181   $  3,601,913  
  Additions   -     17,935     -     224,152     -     242,087  
  Balance, December 31, 2015 $  12,558   $ 2,955,901   $  43,715   $  803,645   $  28,181   $  3,844,000  
  Additions   -     -     -     6,337     -     6,337  
  Balance, June 30, 2016 $  12,558   $ 2,955,901   $  43,715   $  809,982   $  28,181   $  3,850,337  
  Accumulated Amortization                                    
  Balance, December 31, 2014 $  -   $  78,350   $  19,865   $  89,321   $  17,455   $  204,991  
  Amortization   -     115,111     4,770     119,018     3,217     242,116  
  Balance, December 31, 2015 $  -   $  193,461   $  24,635   $  208,339   $  20,672   $  447,107  
  Amortization   -     57,642     2,385     65,401     1,610     127,038  
  Balance, June 30, 2016 $  -   $  251,103   $  27,020   $  273,740   $  22,282   $  574,144  
  Carrying Value                                    
  June 30, 2016 $  12,558   $ 2,704,798   $  16,695   $  536,242   $  5,899   $  3,276,192  
  December 31, 2015 $  12,558   $ 2,762,440   $  19,080   $  595,306   $  7,509   $  3,396,893  

Included in cost of goods sold is $127,038 (2015 - $116,913) of amortization related to property, plant and equipment.

19



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

8.

INTANGIBLE ASSETS


                  Product        
                  Development        
      Patent     Rights     costs     Total  
                           
  Cost                        
  Balance, December 31, 2014 $  40,840   $  65,000   $  298,484   $  404,324  
  Amounts written-off   -     -     (298,484 )   (298,484 )
  Balance, December 31, 2015 $  40,840   $  65,000   $  -   $  105,840  
  Additions   -     -     -     -  
  Balance, June 30, 2016 $  40,840   $  65,000   $  -   $  105,840  
  Accumulated Amortization                        
  Balance, December 31, 2014 $  18,425   $  65,000   $  -   $  83,425  
  Amortization   3,024     -     -     3,024  
  Balance, December 31, 2015 $  21,449   $  -   $  -   $  86,449  
  Amortization   1,512     -     -     1,512  
  Balance, June 30, 2016 $  22,961   $  65,000   $  -   $  87,961  
                           
  Carrying Value                        
  June 30, 2016 $  17,879   $  -   $  -   $  17,879  
  December 31, 2015 $  19,391   $  -   $  -   $  19,391  

Included in cost of goods sold is $1,512 (2015 - $19,033) of amortization related to rights.

The Company is obligated to pay a 5% royalty from sales of their manway securement systems. During the period ended June 30, 2016, there were revenues from sales of the manway securement systems totalling $15,255 (2015 - $859,079). The Company also holds a number of other patents, which have been fully amortized as at June 30, 2016.

On November 28, 2012, the Company signed an agreement to acquire all proprietary manufacturing rights to an ETS for $65,000. The vendor entered into a consulting agreement with the Company for a period of twenty-four months for a fee of $6,500 per month. The Company is obligated to pay a 7% royalty from sales on all ETS sold over the duration of the consulting contract. The contract terminated in December 31, 2014. During the period ended June 30, 2016, there were revenues of $1,950 (2015 - $5,425) from the sales of the ETS.

9.

CAPITAL STOCK

Authorized:

Unlimited Class A non-cumulative, preferred shares without par value, of which 5,000,000 are designated Class A, convertible, voting, preferred shares

Unlimited common shares without par value

20



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

9.

CAPITAL STOCK (Continued)

Issued:

  (a)

Common shares

During the year ended December 31, 2015, the Company issued 825,000 shares pursuant to the exercise of share purchase options for gross proceeds of $223,740.

  (b)

Stock options

The Company has a stock option plan (the “Plan”) available to employees, directors, officers and consultants with grants under the Plan approved from time to time by the Board of Directors. Under the Plan, the Company is authorized to issue options to purchase an aggregate of up to 10% of the Company's issued and outstanding common shares. Each option can be exercised to acquire one common share of the Company. The exercise price for an option granted under the Plan may not be less than the market price at the date of grant less a specified discount dependent on the market price.

Options to purchase common shares have been granted to directors, employees and consultants as follows:

  Exercise         Year Ended                       Period Ended  
  Price   Expiry     December 31                       June 30,  
  (CAD)   Date     2015     Granted     Exercised     Expired     2016  
                                       
  $ 0.58   July 22, 2016     240,000     -     -     -     240,000  
  $ 0.58 (USD)   August 24, 2016     100,000     -     -     -     100,000  
  $ 1.45 (USD)   March 31, 2017     770,000     -     -     -     770,000  
  $ 0.65 (USD)   October 30, 2017     80,000     -     -     -     80,000  
  $ 6.25 (USD)   July 7, 2019     100,000     -     -     100,000     -  
  $ 5.90 (USD)   January 2, 2016     500,000     -     -     500,000     -  
  $ 2.12 (USD)   August 25, 2017     500,000     -     -     100,000     400,000  
  $ 0.70   October 7, 2019     28,571     -     -     -     28,571  
  $ 6.85   November 14, 2019     100,000     -     -     -     100,000  
  Total outstanding         2,418,571     -     -     700,000     1,718,571  
  Total exercisable         2,243,571     -     -     -     1,585,237  

  Exercise         Year Ended                       Year Ended  
  Price   Expiry     December 31                       December 31,  
  (CAD)   Date     2014     Granted     Exercised     Expired     2015  
                                       
  $ 0.24   June 2, 2015     530,000     -     530,000     -     -  
  $ 0.24   October 4, 2015     100,000     -     100,000     -     -  
  $ 0.58   July 22, 2016     365,000     -     125,000     -     240,000  
  $ 0.65 (USD)   October 30, 2017     150,000     -     70,000     -     80,000  
  $ 0.58 (USD)   August 24, 2016     100,000     -     -     -     100,000  
  $1.45 (USD)   March 31, 2017     770,000     -     -     -     770,000  
  $2.12 (USD)   August 25, 2017     -     500,000     -     -     500,000  
  $5.90 (USD)   January 2, 2016     -     500,000     -     -     500,000  
  $ 0.70   October 7, 2019     28,571     -     -     -     28,571  
  $6.85   November 14, 2019     100,000     -     -     -     100,000  
  $6.25 (USD)   July 7, 2019     100,000     -     -     -     100,000  
                                       
  Total outstanding         2,243,571     1,000,000     825,000     -     2,418,571  
  Total exercisable         2,243,571     666,667     825,000     -     2,085,238  

21



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

9.

CAPITAL STOCK (Continued)


  (b)

Stock options (Continued)

A summary of the Company’s stock options as at June 30, 2016 and December 31, 2015, and changes for the periods then ended are as follows:

            Weighted  
            Average Exercise  
      Number     Price (CAD)  
               
  Outstanding, December 31, 2014   2,243,571   $  1.49  
  Granted   1,000,000   $  4.01 (USD)
  Exercised   (825,000 ) $  0.35  
  Outstanding, December 31, 2015   2,418,571   $  3.70  
  Expired   (700,000 ) $  5.40 (USD)
  Outstanding, June 30, 2016   1,718,571   $  1.58 (USD)

The weighted average contractual life for the remaining options at June 30, 2016 is .75 (2015 – 1.23) years.

Share-based expense

Share-based expense of $43,085 (2015 - $540,000), was recognized in the period. No stock options were granted during the period ended June 30, 2016. The share-based expense relates to options granted last year but vest over time.

The fair value of stock options is determined using the Black-Scholes option pricing model with assumptions as follows:

      Six months ended     Six months ended  
      June 30, 2016     June 30, 2015  
               
  Risk-free interest rate (average)   0.77%     1.3%  
  Estimated volatility (average)   52.38%     45%  
  Expected life in years   1.50     5  
  Expected dividend yield   0.00%     0.00%  
  Estimated forfeitures   0.00%     0.00%  
  Grant date fair value per option $ 0.77   $  1.08  

22



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

9.

CAPITAL STOCK (Continued)


  (b)

Stock options (Continued)

Option pricing models require the use of highly subjective estimates and assumptions including the expected stock price volatility. Changes in the underlying assumptions can materially affect the fair value estimates.

  (c)

Share purchase warrants

As at June 30, 2016 the Company has no share purchase warrants outstanding.

10.

RELATED PARTY TRANSACTIONS

Related party transactions not otherwise described in these consolidated financial statements are shown below. The remuneration of the Company’s directors and other members of key management, being the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer and Chief Technical Officer who have the authority and responsibility for planning, directing and controlling the activities of the Company, consist of the following amounts:

      June 30, 2016     June 30, 2015  
               
  Management compensation $  350,764   $  352,541  
  Management bonus* $  -   $  197,293  
  Share-based expense** $  21,542   $  -  
  Directors fees $  33,000   $  -  

 

*

The Company has management bonus agreements whereby 10% of the annual income before taxes and share-based expense is equally distributed to management.

 

 

**

Share-based expense consist of the key management portion of the fair value of options granted calculated using the Black-Scholes option pricing model and does not include any cash compensation.

As at June 30, 2016, amounts due to related parties include accounts payable which are unsecured and have no interest or specific terms of payments, are $3,145 (2015 - $144,888) consisting of $Nil (2015 - $133,362) for management bonus payable and $3,145 (2015 - $11,525) for reimbursement of expenses to a director of the Company.

11.

COMMITMENTS

The Company is committed to making the following payments for base rent on its office in Downers Grove, Illinois:

  2016 $  13,695  
  2017   28,140  
  2018   24,960  
  2019   3,930  
    $  70,725  

The rent expense in the unaudited interim consolidated statements of operation and comprehensive income (loss) for the period ended June 30, 2016 amounted to $15,430 (2015 - $64,405).

23



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

12.

SUPPLEMENTAL CASH FLOW INFORMATION


      June 30, 2016     December 31, 2015  
               
  Non-cash financing activities            
   Amortization of property and equipment allocated to cost of goods sold $  128,650   $  234,177  
   Amortization allocated to inventory $  -   $  7,938  
   Income taxes paid $  -   $  817,774  

      June 30, 2016     December 31, 2015  
               
  Cash and Cash Equivalents is comprised of:            
   Cash $  641,011   $  1,007,792  
   Guaranteed investment certificates   2,322,600     2,167,500  
    $  2,963,611   $  3,175,292  

13.

EARNINGS PER SHARE

The calculation of basic and diluted earnings (loss) per share for the relevant periods are based on the following:

      June 30, 2016     December 31, 2015  
               
  Net income (loss) for the period $  (1,230,243 ) $  (2,510,826 )
               
  Basic weighted average number of common shares outstanding   46,071,752     45,779,903  
  Effect of dilutive securities:            
     Options   448,571     -  
  Diluted weighted average number of common shares outstanding   46,520,323     45,779,903  
               
  Basic earnings (loss) per share $  (0.03 ) $  (0.05 )
  Diluted earnings (loss) per share $  (0.03 ) $  (0.05 )

24



KELSO TECHNOLOGIES INC.
Notes to Consolidated Interim Financial Statements
For the six months ended June 30, 2016 and 2015
(Unaudited – Prepared by Management)
(Expressed in US Dollars)
 

14.

SIGNIFICANT CUSTOMERS

The following table represents sales to individual customers exceeding 10% of the Company’s quarterly revenues:

      June 30, 2016     June 30, 2015  
               
  Customer A $  1,852,313   $  5,740,396  
  Customer B $  990,313   $  1,495,725  
  Customer C $  -   $  1,457,712  

All customers are major US and Canadian corporations, who have displayed a pattern of consistent timely payment of accounts owing.

15.

EMPLOYEE BENEFITS

Total employee benefit expenses, including salary and wages, management compensation, share-based expense and benefits for the period ended June 30, 2016 amounted to $1,469,573 (2015 - $2,688,824).

16.

SEGMENTED INFORMATION

The Company operates primarily in one business segment, the design, production and distribution of various proprietary pressure relief valves, with operations located in the United States.

25